BMRN

NASDAQ 已收盘

BioMarin Pharmaceutical

61.42 USD
▼-0.01-0.02%
盘后 60.16 -2.05%
2026-11-19
市值
$11.82B
市盈率
151.70
EPS
-0.10
股息率
—
52 周区间
49.26 – 70.98
成交量
5.20M
Beta
0.23
目标价
90.30
52W 低 49.2652W 高 70.98
价格走势

公司简介

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company’s products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NA...

关联新闻